KATNBL1

Across TCGA pan-cancer cohorts, KATNBL1 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated KATNBL1 data layer compared with 25 for mass-spec protein and 4 for mutation status.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher KATNBL1 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated KATNBL1 expression acts as an unfavorable survival marker, although some lineages such as LSCC show a favorable association.

LUAD, LSCC, and PDAC are the cancer types where KATNBL1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Tertile	All	0.599	0.847	.013	17	view →
LSCC	DFS	Quartile	All	1.000	0.846	.016	8	view →
PDAC	DFS	Median	All	0.581	1.000	.020	1	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

KATNBL1–LUAD (DFS)

Open the LUAD breakdown →